Project | Basic data |
---|---|
Age (years old) | 69.92 ± 13.94 |
Male [Case (%)] | 62 (54.9%) |
Type of HF [Case (%)] | |
HFpEF | 60 (53.1%) |
HFmrEF | 28 (24.8%) |
HFrEF | 25 (22.1%) |
Premedication history [Case (%)] | |
Cardiotonic | 36 (31.9%) |
Diuretic | 75 (66.4%) |
Aldosterone receptor antagonist | 31 (27.4%) |
ACEI/ ARB | 42 (38.1%) |
β receptor blocker | 32 (28.3%) |
Calcium channel antagonist | 40 (35.4%) |
Aspirin/Clopidogrel | 44 (38.9%) |
Statins | 46 (40.7%) |
Complication [Case (%)] | |
Coronary heart disease [Case (%)] | 47 (41.6%) |
Hypertension [Case (%)] | 71 (62.8%) |
Diabetes Mellitus [Case (%)] | 46 (40.7%) |
Atrial fibrillation [Case (%)] | 51 (45.1%) |
Smoke History [Case (%)] | 28 (24.8%) |